Conclusion

 Europe must move forward
 
In order for agricultural biotechnology to contribute actively to Europe meeting the Lisbon goals, European political leaders and the European Commission should review their biotechnology and life sciences policies to ensure that they:
 
 1. Honour commitments aimed at achieving political and economic objectives.
 
 2. Fulfil their legal obligations and properly implement Community legislation.
 
 3. Encourage EFSA to deliver safety opinions on biotech products within the times prescribed in the Community legislation.
 
 4. Propose draft decisions for placing on the market of biotech products in a timely manner as required by the Community legislation.
 
 5. Establish pragmatic labelling thresholds for adventitious or technically unavoidable presence of biotech seeds in seed lots.
 
 6. Establish pragmatic approach to manage the presence of low levels of biotech products and derived biotech material in traded commodities.
 
 7. Enhance the co-ordination with Member States as far as co-existence is concerned.
 
 8. Listen to, and more vocally support, European farmers to realize the economic and environmental advantages of green biotechnology.
 
 9. Nurture and promote coherent pro-growth and pro-development policies that do not discriminate against this promising technology.
 
 10. Better contribute toward educating citizens about the technology, its safety, its advantages and the regulatory framework.